This activity is supported by an educational grant from Biotheranostics, Inc.
Expiration Date: 6/10/2020
Multigene assays that evaluate an array of prognostic and/or predictive molecular markers have become critical for the optimal management of patients with breast cancer…go to activity»
This activity is sponsored by Novartis Pharmaceuticals Corporation.
June 12, 2018
Discover key efficacy and safety data as well as patient case studies for a therapy for patients with BRAF+ stage III or metastatic melanoma
.go to activity»
This activity is supported by an independent educational grant from Pfizer, Inc.
Expiration Date: 4/29/2020
In this activity, Bruno Medieros, MD, and Farhad Ravandi-Kashini, MD, discuss recent advances in the treatment of acute myeloid leukemia (AML). They discuss how new…go to activity»
This activity is supported by an educational grant from Bristol-Myers Squibb.
Expiration Date: 4/30/2020
For patients diagnosed with metastatic melanoma, the lifetime incidence of brain metastasis is more than 50% and is associated with a poor prognosis. The approval and…go to activity»
There is no commercial support for this activity.
Expiration Date: 4/14/2020
This educational activity will utilize a case study to discuss the assessment and management of a 67-year-old man who presents with pain and swelling of his hands and…go to activity»
Raoul Tibes, MD, PhD, is an associate professor in the department of medicine at New York University School of Medicine and director of the clinical leukemia program at…go to activity»